Karyopharm Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -67.5% | -67.5% | -60.7% |
| FY2017 | -99.6% | -99.6% | -71.5% |
| FY2018 | -97.4% | -97.4% | -52.3% |
| FY2019 | -401.0% | -401.0% | -67.7% |
| FY2020 | -388.3% | -388.3% | -62.7% |
| FY2021 | 155.7% | -138.5% | -40.6% |
| FY2022 | 992.4% | 992.4% | -46.1% |
| FY2023 | 105.1% | 105.1% | -59.5% |
| FY2024 | 41.1% | 41.1% | -46.5% |
| FY2025 | 66.9% | 66.9% | -180.8% |